<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../4_X02.xsl"?><ownershipDocument>    <schemaVersion>X0303</schemaVersion>    <documentType>4</documentType>    <periodOfReport>2011-05-18</periodOfReport>    <notSubjectToSection16>0</notSubjectToSection16>    <issuer>        <issuerCik>0001138400</issuerCik>        <issuerName>BIOMIMETIC THERAPEUTICS, INC.</issuerName>        <issuerTradingSymbol>BMTI</issuerTradingSymbol>    </issuer>    <reportingOwner>        <reportingOwnerId>            <rptOwnerCik>0001362148</rptOwnerCik>            <rptOwnerName>Lynch Samuel Eugene</rptOwnerName>        </reportingOwnerId>        <reportingOwnerAddress>            <rptOwnerStreet1>BIOMIMETIC THERAPEUTICS, INC.</rptOwnerStreet1>            <rptOwnerStreet2>389 NICHOL MILL LANE</rptOwnerStreet2>            <rptOwnerCity>FRANKLIN</rptOwnerCity>            <rptOwnerState>TN</rptOwnerState>            <rptOwnerZipCode>37067</rptOwnerZipCode>            <rptOwnerStateDescription></rptOwnerStateDescription>        </reportingOwnerAddress>        <reportingOwnerRelationship>            <isDirector>1</isDirector>            <isOfficer>1</isOfficer>            <isTenPercentOwner>0</isTenPercentOwner>            <isOther>0</isOther>            <officerTitle>President and CEO</officerTitle>        </reportingOwnerRelationship>    </reportingOwner>    <nonDerivativeTable>        <nonDerivativeTransaction>            <securityTitle>                <value>Common Stock</value>            </securityTitle>            <transactionDate>                <value>2011-05-18</value>            </transactionDate>            <deemedExecutionDate></deemedExecutionDate>            <transactionCoding>                <transactionFormType>4</transactionFormType>                <transactionCode>P</transactionCode>                <equitySwapInvolved>0</equitySwapInvolved>            </transactionCoding>            <transactionTimeliness>                <value></value>            </transactionTimeliness>            <transactionAmounts>                <transactionShares>                    <value>10000</value>                </transactionShares>                <transactionPricePerShare>                    <value>7.90</value>                </transactionPricePerShare>                <transactionAcquiredDisposedCode>                    <value>A</value>                </transactionAcquiredDisposedCode>            </transactionAmounts>            <postTransactionAmounts>                <sharesOwnedFollowingTransaction>                    <value>895912</value>                    <footnoteId id="F1"/>                </sharesOwnedFollowingTransaction>            </postTransactionAmounts>            <ownershipNature>                <directOrIndirectOwnership>                    <value>D</value>                </directOrIndirectOwnership>            </ownershipNature>        </nonDerivativeTransaction>        <nonDerivativeTransaction>            <securityTitle>                <value>Common Stock</value>            </securityTitle>            <transactionDate>                <value>2011-05-18</value>            </transactionDate>            <deemedExecutionDate></deemedExecutionDate>            <transactionCoding>                <transactionFormType>4</transactionFormType>                <transactionCode>P</transactionCode>                <equitySwapInvolved>0</equitySwapInvolved>            </transactionCoding>            <transactionTimeliness>                <value></value>            </transactionTimeliness>            <transactionAmounts>                <transactionShares>                    <value>3000</value>                </transactionShares>                <transactionPricePerShare>                    <value>7.75</value>                </transactionPricePerShare>                <transactionAcquiredDisposedCode>                    <value>A</value>                </transactionAcquiredDisposedCode>            </transactionAmounts>            <postTransactionAmounts>                <sharesOwnedFollowingTransaction>                    <value>898912</value>                </sharesOwnedFollowingTransaction>            </postTransactionAmounts>            <ownershipNature>                <directOrIndirectOwnership>                    <value>D</value>                </directOrIndirectOwnership>            </ownershipNature>        </nonDerivativeTransaction>        <nonDerivativeHolding>            <securityTitle>                <value>Common Stock</value>            </securityTitle>            <postTransactionAmounts>                <sharesOwnedFollowingTransaction>                    <value>254341</value>                </sharesOwnedFollowingTransaction>            </postTransactionAmounts>            <ownershipNature>                <directOrIndirectOwnership>                    <value>I</value>                </directOrIndirectOwnership>                <natureOfOwnership>                    <value>By Trust</value>                    <footnoteId id="F2"/>                </natureOfOwnership>            </ownershipNature>        </nonDerivativeHolding>        <nonDerivativeHolding>            <securityTitle>                <value>Common Stock</value>            </securityTitle>            <postTransactionAmounts>                <sharesOwnedFollowingTransaction>                    <value>5100</value>                </sharesOwnedFollowingTransaction>            </postTransactionAmounts>            <ownershipNature>                <directOrIndirectOwnership>                    <value>I</value>                </directOrIndirectOwnership>                <natureOfOwnership>                    <value>By Wife</value>                    <footnoteId id="F3"/>                </natureOfOwnership>            </ownershipNature>        </nonDerivativeHolding>    </nonDerivativeTable>    <footnotes>        <footnote id="F1">The balance of common stock beneficially owned includes shares acquired by the Reporting Person since the previous Form 4 filing (on 1/21/2011), consisting of 1,898 shares purchased through the Issuer's Employee Stock Purchase Plan for the 1st quarter 2011.</footnote>        <footnote id="F2">Shares are held in an irrevocable trust fund, of which Samuel E. Lynch is trustee.</footnote>        <footnote id="F3">Dr. Lynch disclaims beneficial ownership of these shares except to the extent of his pecuniary interest in them.</footnote>    </footnotes>    <remarks></remarks>    <ownerSignature>        <signatureName>/s/ Luke Durben, Attorney-in-Fact for Samuel E. Lynch</signatureName>        <signatureDate>2011-05-19</signatureDate>    </ownerSignature></ownershipDocument>